EUVIMEDEUVIMED entdecken
Open Access

Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings

Daria Piacentino, Gabriele Sani, Georgios D Kotzalidis, Simone Cappelletti, Livia Longo, Salvatore Rizzato, Francesco Fabi, Paola Frati, Vittorio Fineschi, Lorenzo Leggio

Human Psychopharmacology: Clinical and Experimental · 2022-01 · 37 (1)

DOI: 10.1002/hup.2815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 15.09.2021. Verfasst von Daria Piacentino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intr…. Hauptthemen laut MEDLINE: Anabolic Agents, Mental Disorders, Performance-Enhancing Substances. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of anabolic androgenic steroids (AASs) as performance and image enhancing drugs (PIEDs), once restricted to professional athletes, now includes amateurs and regular gym visitors. AAS use is associated with psychopathology, yet this relationship is complex and not fully understood. We aimed to assess the presence of AASs and other misused substances in athletes' biological samples and link toxicological to psychopathological findings.

Methods

A multicentre, cross‐sectional study in fitness centres in Italy recruited 122 professional and amateur athletes training in several sports (84 men; age range = 18‐45 years). Athletes completed questionnaires, interviews, and toxicology testing for AASs, other PIEDs, illicit drugs, and non‐prescribed psychotropics. Toxicology was conducted in blood, urine, and hair.

Results

Self‐reported and toxicologically detected use rates of AASs and other misused substances showed slight‐to‐fair agreement (Fleiss' κ = 0.104‐0.375). There was slight‐to‐moderate agreement among the three biological samples used for AAS testing ( κ = 0.112‐0.436). Thirty‐one athletes (25.4%) tested positive for AASs. More sport hours/week, narcissistic or antisocial personality disorders, and higher nonplanning impulsiveness scores predicted AAS use (pseudo‐ R 2 = 0.665). AAS users did not differ significantly from non‐users in major psychopathology, but their Hypomania Checklist‐32 score, which also predicted AAS use, was significantly higher ( p < 0.001), suggesting increased odds for cyclothymic disorder or subthreshold hypomania.

Conclusions

Our results have implications for studying AAS users, as they identify a cluster of variables that may be relevant in future understanding of AAS use risks (e.g., personality disorders). Possible disagreements between AAS assessment methods should be considered when implementing harm reduction interventions, such as needle and syringe distribution, health education, and counselling, as well as surveillance programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anabolic AgentsMental DisordersPerformance-Enhancing SubstancesAdolescentAdultAthletesCross-Sectional StudiesHumansMaleMiddle AgedSteroidsYoung Adult

Stichwörter der Autor:innen

anabolic androgenic steroidsathletesperformance and image enhancing drugspsychopathologytoxicology

Substanzen

Anabolic AgentsPerformance-Enhancing SubstancesSteroids

Autor:innen und Institutionen

  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, National Institute on Alcohol Abuse and Alcoh…
  • Center on Compulsive Behaviors, National Institutes of Health, Baltimore, Maryland, USA.
  • Department of Neurosciences, Mental Health, and Sensory Organs, School of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
  • Department of Neuroscience, Psychiatry Section, Catholic University of Rome, Rome, Italy.
  • Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.
  • Center for Statistical and Social Studies (CE3S), Rome, Italy.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Piacentino, D., Sani, G., Kotzalidis, G. D., Cappelletti, S., Longo, L., Rizzato, S., Fabi, F., Frati, P., Fineschi, V., & Leggio, L. (2022). Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings. Human Psychopharmacology: Clinical and Experimental, 37(1). https://doi.org/10.1002/hup.2815

Vancouver

Piacentino D, Sani G, Kotzalidis GD, Cappelletti S, Longo L, Rizzato S, et al. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings. Human Psychopharmacology: Clinical and Experimental. 2022;37(1). doi:10.1002/hup.2815

BibTeX
@article{Piacentino2022,
  author = {Piacentino, Daria and Sani, Gabriele and Kotzalidis, Georgios D and Cappelletti, Simone and Longo, Livia and Rizzato, Salvatore and Fabi, Francesco and Frati, Paola and Fineschi, Vittorio and Leggio, Lorenzo},
  title = {Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2022},
  volume = {37},
  number = {1},
  doi = {10.1002/hup.2815}
}
Kostenlos starten →